X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (143) 143
humans (123) 123
alzheimer's disease (120) 120
mild cognitive impairment (101) 101
florbetapir f 18 (92) 92
male (88) 88
florbetapir (86) 86
aged (85) 85
female (84) 84
pet (79) 79
dementia (76) 76
alzheimers-disease (73) 73
positron-emission tomography (71) 71
positron-emission-tomography (70) 70
neurosciences (69) 69
amyloid (67) 67
alzheimer disease - diagnostic imaging (65) 65
clinical neurology (57) 57
brain - diagnostic imaging (53) 53
aged, 80 and over (48) 48
brain (48) 48
middle aged (46) 46
alzheimer’s disease (45) 45
positron emission tomography (45) 45
radiology, nuclear medicine & medical imaging (45) 45
pet imaging (44) 44
diagnosis (42) 42
neurology (42) 42
aniline compounds (41) 41
neuroimaging (41) 41
ethylene glycols (40) 40
pittsburgh compound-b (40) 40
biomarkers (37) 37
positron-emission tomography - methods (37) 37
magnetic resonance imaging (35) 35
medicine & public health (35) 35
alzheimer disease - metabolism (34) 34
amyloid beta-peptides - metabolism (34) 34
radiopharmaceuticals (33) 33
amyloid - metabolism (31) 31
article (31) 31
brain - metabolism (31) 31
deposition (31) 31
nuclear medicine (31) 31
alzheimers disease (26) 26
cognitive dysfunction - diagnostic imaging (23) 23
imaging / radiology (23) 23
medical imaging (23) 23
national institute (23) 23
pathology (22) 22
alzheimer disease - pathology (21) 21
f 18 (21) 21
geriatrics & gerontology (21) 21
alzheimer disease (20) 20
tomography (20) 20
a-beta (19) 19
cardiology (19) 19
cognitive ability (19) 19
neuropsychological tests (19) 19
oncology (19) 19
orthopedics (19) 19
alzheimer disease - diagnosis (18) 18
beta (18) 18
mental disorders (18) 18
quantification (18) 18
brain - pathology (17) 17
diagnostic imaging (17) 17
disease progression (17) 17
in-vivo (17) 17
memory (17) 17
usage (17) 17
amyloid imaging (16) 16
amyloid pet (16) 16
diagnostic guidelines (16) 16
amyloid-beta (15) 15
amyloidosis (15) 15
animals (15) 15
florbetapir-pet (15) 15
β-amyloid (15) 15
cerebrospinal fluid (14) 14
disease (14) 14
original (14) 14
psychiatry (14) 14
research (14) 14
beta-amyloid (13) 13
fdg-pet (13) 13
plaque, amyloid - diagnostic imaging (13) 13
positron emission (13) 13
aging (12) 12
aniline compounds - metabolism (12) 12
biomarker (12) 12
cognition (12) 12
cognitive dysfunction - metabolism (12) 12
cross-sectional studies (12) 12
impairment (12) 12
neurodegenerative diseases (12) 12
adult (11) 11
amyloid beta-peptides - cerebrospinal fluid (11) 11
case-control studies (11) 11
cognitive impairment (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Psychiatry, ISSN 1359-4184, 09/2014, Volume 19, Issue 9, pp. 1044 - 1051
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 03/2012, Volume 53, Issue 3, pp. 378 - 384
Journal Article
Alzheimer Disease & Associated Disorders, ISSN 0893-0341, 07/2019, Volume 33, Issue 3, pp. 282 - 284
The use of biomarkers has recently supported the association between Alzheimer disease (AD) pathology and the logopenic variant of primary progressive aphasia... 
biomarkers | F-florbetapir PET | amyloid beta pathology | primary progressive aphasia | cerebrospinal fluid | VARIANTS | DISEASE | PATHOLOGY | CLINICAL NEUROLOGY
Journal Article
Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 11/2019, Volume 39, Issue 11, pp. 2172 - 2180
Accumulation of amyloid beta can be visualized using [18F]florbetapir positron emission tomography. The aim of this study was to identify the optimal model for... 
tracer kinetic modelling | Amyloid positron emission tomography | test–retest | [ | Alzheimer’s disease | F]florbetapir
Journal Article
Translational Psychiatry, ISSN 2158-3188, 09/2016, Volume 6, Issue 9, pp. e900 - e900
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder most commonly associated with repetitive traumatic brain injury (TBI) and characterized... 
POSITRON-EMISSION-TOMOGRAPHY | ROBUST | BRAIN-INJURY | BROCAS AREA | PSYCHIATRY | ALZHEIMERS-DISEASE | BASAL GANGLIA | BINDING CHARACTERISTICS | CHRONIC TRAUMATIC ENCEPHALOPATHY | FLORBETAPIR | PET | Original
Journal Article
Alzheimer Disease and Associated Disorders, ISSN 0893-0341, 01/2012, Volume 26, Issue 1, pp. 8 - 16
Journal Article
Journal Article
Journal of Nuclear Medicine Technology, ISSN 0091-4916, 2015, Volume 43, Issue 3, pp. 175 - 184
Journal Article
International Journal of Geriatric Psychiatry, ISSN 0885-6230, 05/2015, Volume 30, Issue 5, pp. 505 - 513
Journal Article
NeuroImage: Clinical, 01/2019, Volume 22, p. 101771
Disease-modifying treatment trials are increasingly advanced to the prodromal or preclinical phase of Alzheimer's disease (AD), and inclusion criteria are... 
Florbetapir | Mild cognitive impairment | Biomarkers | Hippocampal volume | Cerebrospinal fluid | Alzheimer's disease | Positron emission tomography
Journal Article
Journal Article